BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9083912)

  • 21. In vitro inhibition of peptic degradation of porcine gastric mucus glycoprotein by sucralfate.
    Slomiany BL; Laszewicz W; Slomiany A
    Scand J Gastroenterol; 1985 Sep; 20(7):857-60. PubMed ID: 3931205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of mucus and prostaglandins in the gastric mucosal protective actions of sucralfate against ethanol-induced injury in the rat.
    Quadros E; Ramsamooj E; Wilson DE
    Am J Med; 1987 Sep; 83(3B):19-23. PubMed ID: 3477959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect and mechanism of sucralfate on healing of acetic acid-induced gastric ulcers in rats.
    Ogihara Y; Okabe S
    J Physiol Pharmacol; 1993 Jun; 44(2):109-18. PubMed ID: 8358048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of acid milieu in the gastroprotective and ulcer-healing activity of sucralfate.
    Konturek SJ; Brzozowski T; Drozdowicz D; Garlicki J; Majka J; Pytko-Polonczyk J
    Am J Med; 1991 Aug; 91(2A):20S-29S. PubMed ID: 1882904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin renders the oesophageal mucosa more permeable to acid and pepsin.
    Lanas AI; Sousa FL; Ortego J; Esteva F; Blas JM; Soria J; Sáinz R
    Eur J Gastroenterol Hepatol; 1995 Nov; 7(11):1065-72. PubMed ID: 8680906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stress bleeding prophylaxis with sucralfate. Pathophysiologic basis and clinical use.
    Tryba M
    Scand J Gastroenterol Suppl; 1990; 173():22-33. PubMed ID: 1693444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influences of pepsin concentrations and pH levels on the disinfective activity of ozone nanobubble water against helicobacter pylori.
    Kawara F; Inoue J; Takenaka M; Hoshi N; Masuda A; Nishiumi S; Kutsumi H; Azuma T; Ohdaira T
    Digestion; 2014; 90(1):10-7. PubMed ID: 25096714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sucralfate protection of the gastric mucosa against ethanol-induced injury: a prostaglandin-mediated process?
    Hollander D; Tarnawski A; Gergely H; Zipser RD
    Scand J Gastroenterol Suppl; 1984; 101():97-102. PubMed ID: 6599542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of growth factors on acid-induced damage to rat gastric epithelial cells.
    Furukawa O; Okabe S
    J Clin Gastroenterol; 1997; 25 Suppl 1():S79-83. PubMed ID: 9479630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ranitidine and sucralfate on ketoconazole bioavailability.
    Piscitelli SC; Goss TF; Wilton JH; D'Andrea DT; Goldstein H; Schentag JJ
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1765-71. PubMed ID: 1952845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial killing in gastric juice--effect of pH and pepsin on Escherichia coli and Helicobacter pylori.
    Zhu H; Hart CA; Sales D; Roberts NB
    J Med Microbiol; 2006 Sep; 55(Pt 9):1265-1270. PubMed ID: 16914658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of sucralfate on gastric mucosal blood flow in rats.
    Chen BW; Hiu WM; Lam SK; Cho CH; Ng MM; Luk CT
    Gut; 1989 Nov; 30(11):1544-51. PubMed ID: 2599440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intragastric pH on mucosal protective action of sucralfate.
    Danesh JZ; Duncan A; Russell RI; Mitchell G
    Gut; 1988 Oct; 29(10):1379-85. PubMed ID: 3197982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sucralfate on gastric mucosal inflammatory responses induced by Helicobacter pylori lipopolysaccharide.
    Slomiany BL; Piotrowski J; Slomiany A
    Scand J Gastroenterol; 1998 Sep; 33(9):916-22. PubMed ID: 9759945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sucralfate prevents experimental peptic esophagitis in rabbits.
    Schweitzer EJ; Bass BL; Johnson LF; Harmon JW
    Gastroenterology; 1985 Mar; 88(3):611-9. PubMed ID: 3917956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of sucralfate-mediated preservation of growth factor bioactivity in the presence of low pH with a human gastric epithelial cell line (AGS).
    Sheng H; Shah PK; Audus KL
    Pharm Res; 1996 Jul; 13(7):1122-6. PubMed ID: 8842056
    [No Abstract]   [Full Text] [Related]  

  • 37. Sucralfate protection against gastrointestinal damage: possible role of prostanoids.
    Ligumsky M; Karmeli F; Rachmilewitz D
    Isr J Med Sci; 1986 Nov; 22(11):801-6. PubMed ID: 3098700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The protective effect of sucralfate on the gastric mucosa of rats.
    Harrington SJ; Schlegel JF; Code CF
    J Clin Gastroenterol; 1981; 3(Suppl 2):129-34. PubMed ID: 6895643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric resistance to acid: is the "mucus-bicarbonate barrier" functionally redundant?
    Wallace JL
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G31-8. PubMed ID: 2492159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ablation of capsaicin-sensitive neurons on gastric protection by honey and sucralfate.
    al-Swayeh OA; Ali AT
    Hepatogastroenterology; 1998; 45(19):297-302. PubMed ID: 9496530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.